fda glp-1 compounding warning letters september 2025 issued 25 to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA issued 25 warning letters
Description
Weight is the primary metric by which anti-obesity drugs are judged and distributed, but weight and BMI are poor measures for visceral fat
Amazon Pharmacy kiosks are extending access beyond home delivery into physical, self-service touchpoints
Compare 5 ways to save on Repatha with or without insurance

Heres what not to sayand how not to say it.

Medical Director Guy Slater explains the real risks with GLP-1's and pancreatitis and why they remain safe and effective for weight loss.
